MedPath

NU-DERM system NORMAL-DRY

OBAGI NU-DERM SYSTEM

Approved
Approval ID

e2fd24f9-f517-4b21-812c-ad4d56c27bc4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2023

Manufacturers
FDA

OBAGI COSMECEUTICAL LLC

DUNS: 790553353

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydroquinone, Homosalate, Octisalate, and Zinc Oxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62032-532
Product Classification
G
Generic Name
Hydroquinone, Homosalate, Octisalate, and Zinc Oxide
Product Specifications
Effective DateJanuary 26, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NU-DERM system NORMAL-DRY - FDA Drug Approval Details